CASI Pharmaceuticals (CASI) Short Interest Ratio & Short Volume $2.34 -0.03 (-1.27%) As of 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CASI Pharmaceuticals Short Interest DataCASI Pharmaceuticals (CASI) has a short interest of 27,400 shares, representing 0.57% of the float (the number of shares available for trading by the public). This marks a -24.10% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 85,225 shares to cover all short positions.Current Short Interest27,400 sharesPrevious Short Interest36,100 sharesChange Vs. Previous Month-24.10%Dollar Volume Sold Short$61,650.00Short Interest Ratio0.9 Days to CoverLast Record DateFebruary 28, 2025Outstanding Shares15,493,000 sharesFloat Size4,770,000 sharesShort Percent of Float0.57%Today's Trading Volume182 sharesAverage Trading Volume85,225 sharesToday's Volume Vs. Average0% Short Selling CASI Pharmaceuticals? Sign up to receive the latest short interest report for CASI Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCASI Short Interest Over TimeCASI Days to Cover Over TimeCASI Percentage of Float Shorted Over Time Remove Ads CASI Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/202527,400 shares $61,650.00 -24.1%0.6%0.9 $2.25 2/15/202536,100 shares $90,250.00 -2.7%0.8%1 $2.50 1/31/202537,100 shares $91,637.00 +17.0%0.8%1 $2.47 1/15/202531,700 shares $80,518.00 -48.0%0.8%0.7 $2.54 12/31/202461,000 shares $172,630.00 +43.5%1.6%1.3 $2.83 12/15/202442,500 shares $132,175.00 -4.9%1.1%1 $3.11 11/30/202444,700 shares $169,860.00 -0.5%1.2%1.2 $3.80 11/15/202444,900 shares $239,317.00 -40.6%1.2%1.5 $5.33 10/31/202475,600 shares $452,844.00 -31.3%1.9%2.8 $5.99 10/15/2024110,000 shares $613,800.00 -24.9%2.6%4.1 $5.58 Get the Latest News and Ratings for CASI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CASI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/30/2024146,500 shares $873,140.00 -9.4%3.4%4.3 $5.96 9/15/2024161,700 shares $1.16 million -2.9%3.8%0.7 $7.17 8/31/2024166,600 shares $1.10 million -3.1%3.9%0.7 $6.59 8/15/2024172,000 shares $1.13 million -15.1%4.0%0.7 $6.56 7/31/2024202,600 shares $1.47 million -6.9%3.2%0.8 $7.25 7/15/2024217,600 shares $1.36 million -58.9%3.4%0.9 $6.25 6/30/2024529,600 shares $2.91 million +771.1%8.2%2.3 $5.50 6/15/202460,800 shares $189,088.00 -23.7%0.9%1.1 $3.11 5/31/202479,700 shares $307,960.80 +50.1%1.3%2 $3.86 5/15/202453,100 shares $180,009.00 +14.7%0.8%0.3 $3.39 4/30/202446,300 shares $106,490.00 -25.9%0.7%0.2 $2.30 4/15/202462,500 shares $153,125.00 -24.0%1.0%0.3 $2.45 3/31/202482,200 shares $296,742.00 -35.4%1.3%0.4 $3.61 3/15/2024127,300 shares $404,814.00 +204.6%2.2%0.7 $3.18 2/29/202441,800 shares $233,662.00 -21.3%0.7%0.2 $5.59 2/15/202453,100 shares $323,379.00 +0.8%0.9%1.1 $6.09 1/31/202452,700 shares $361,522.00 +10.0%0.9%1 $6.86 1/15/202447,900 shares $291,232.00 +74.8%0.8%0.9 $6.08 12/31/202327,400 shares $196,184.00 -18.7%0.5%0.5 $7.16 12/15/202333,700 shares $206,581.00 -58.4%0.6%0.6 $6.13 11/30/202381,000 shares $452,790.00 -46.4%1.4%1.9 $5.59 11/15/2023151,200 shares $657,720.00 -33.0%2.5%4.9 $4.35 10/31/2023225,700 shares $911,828.00 +0.6%3.4%9 $4.04 10/15/2023224,400 shares $587,928.00 -2.6%3.4%12 $2.62 9/30/2023230,400 shares $589,824.00 -1.5%3.5%15.8 $2.56 9/15/2023233,900 shares $493,529.00 -1.6%3.5%22.1 $2.11 8/31/2023237,600 shares $548,856.00 -1.4%3.6%9.1 $2.31 8/15/2023241,000 shares $535,020.00 +2.4%3.6%8.1 $2.22 7/31/2023235,300 shares $571,779.00 -3.6%3.5%7.7 $2.43 7/15/2023244,100 shares $646,865.00 -2.6%3.7%8.2 $2.65The Crypto Market is About to Change Lives (Ad)We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! 6/30/2023250,700 shares $624,243.00 -7.4%3.8%6.9 $2.49 6/15/2023270,800 shares $557,848.00 +12.6%4.1%5.2 $2.06 5/31/2023240,500 shares $678,210.00 -5.1%3.4%6.5 $2.82 5/15/2023253,300 shares $640,646.36 -0.7%3.6%7.3 $2.53 4/30/2023255,200 shares $730,382.40 -5.0%3.6%7.3 $2.86 4/15/2023268,700 shares $964,633.00 +6.5%3.6%7.1 $3.59 3/31/2023252,200 shares $585,104.00 +3.4%2.7%6.4 $2.32 3/15/2023244,000 shares $417,240.00 -6.1%2.6%9.1 $1.71 2/28/2023259,700 shares $501,221.00 -1.7%2.8%8.3 $1.93 2/15/2023264,300 shares $509,781.84 +0.9%2.2%8 $1.93 1/31/2023262,000 shares $534,480.00 -5.7%2.0%7.8 $2.04 1/15/2023277,800 shares $548,655.00 -5.9%2.1%8.2 $1.98 12/30/2022295,200 shares $528,408.00 +44.1%2.3%8.7 $1.79 12/15/2022204,900 shares $370,869.00 +77.6%1.6%5.5 $1.81 11/30/2022115,400 shares $229,646.00 +27.4%0.9%2.6 $1.99 11/15/202290,600 shares $176,670.00 -13.6%0.7%1.6 $1.95 10/31/2022104,900 shares $206,653.00 -9.6%1.0%0.6 $1.97 10/15/2022116,000 shares $257,520.00 +26.2%1.1%0.6 $2.22 9/30/202291,900 shares $238,940.00 -41.5%0.9%0.4 $2.60 9/15/2022157,200 shares $664,956.00 +28.9%1.5%0.7 $4.23 8/31/2022122,000 shares $457,500.00 -57.1%1.2%0.6 $3.75 8/15/2022284,500 shares $1.14 million +94.5%2.7%1.3 $4.02 7/31/2022146,300 shares $361,361.00 -18.8%1.4%1.5 $2.47 7/15/2022180,100 shares $491,673.00 -14.9%1.7%2.5 $2.73 6/30/2022211,700 shares $605,462.00 +28.9%2.0%3.1 $2.86 6/15/2022164,300 shares $509,330.00 +89.9%1.8%2.4 $3.10 5/31/202286,500 shares $297,560.00 -85.9%N/A1.4 $3.44 5/15/2022612,700 shares $213,525.95 +2.1%0.7%1.8 $0.35 4/30/2022600,200 shares $258,086.00 -5.2%0.7%1.5 $0.43 4/15/2022633,400 shares $393,341.40 -26.7%0.7%1.3 $0.62 3/31/2022863,900 shares $699,499.83 -10.8%1.0%1.4 $0.81 3/15/2022968,800 shares $773,974.32 -19.3%1.1%1.5 $0.80 2/28/20221,200,000 shares $1.01 million -4.0%1.4%1.6 $0.84 2/15/20221,250,000 shares $1.02 million -22.4%1.4%1.4 $0.82 1/31/20221,610,000 shares $1.08 million +1.9%1.8%1.4 $0.67 1/15/20221,580,000 shares $1.14 million -25.8%N/A1.3 $0.72 12/31/20212,130,000 shares $1.70 million -9.4%2.4%1.7 $0.80 12/15/20212,350,000 shares $1.89 million -27.5%2.7%1.6 $0.80 11/30/20213,240,000 shares $2.90 million +14.5%3.7%1.4 $0.90 11/15/20212,830,000 shares $2.89 million -8.7%3.2%1.2 $1.02 10/29/20213,100,000 shares $3.35 million +12.3%3.5%1.2 $1.08 10/15/20212,760,000 shares $3.17 million +11.7%3.1%1.1 $1.15 9/30/20212,470,000 shares $2.94 million -10.5%2.8%1.1 $1.19 9/15/20212,760,000 shares $4.08 million -34.1%3.1%1.3 $1.48 8/31/20214,190,000 shares $6.70 million +28.9%4.7%3.1 $1.60 8/13/20213,250,000 shares $4.26 million +5.5%3.7%2.6 $1.31 7/30/20213,080,000 shares $3.57 million -2.2%3.5%3.4 $1.16 7/15/20213,150,000 shares $4.22 million -2.8%3.5%2.3 $1.34 6/30/20213,240,000 shares $5.02 million -40.1%3.6%2.2 $1.55 6/15/20215,410,000 shares $8.93 million +1.5%6.1%2.6 $1.65The Crypto Market is About to Change Lives (Ad)We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! 5/28/20215,330,000 shares $8.53 million +24.0%6.0%2.7 $1.60 5/14/20214,300,000 shares $6.11 million +24.3%4.8%2.3 $1.42 4/30/20213,460,000 shares $6.26 million +52.4%3.9%1.9 $1.81 4/15/20212,270,000 shares $4.27 million +8.6%2.7%1.6 $1.88 3/31/20212,090,000 shares $4.16 million +22.9%2.7%1.7 $1.99 3/15/20211,700,000 shares $4.22 million -3.4%2.3%3.3 $2.48 2/26/20211,760,000 shares $4.38 million +6.7%2.4%3.7 $2.49 2/12/20211,650,000 shares $4.95 million -9.8%2.3%3.2 $3.00 1/29/20211,830,000 shares $6.28 million +2.2%2.5%3.9 $3.43 1/15/20211,790,000 shares $5.96 million -3.2%2.5%3.3 $3.33 12/31/20201,850,000 shares $5.48 million -2.1%2.6%4 $2.96 12/15/20201,890,000 shares $4.59 million +1.6%2.6%4.4 $2.43 11/30/20201,860,000 shares $4.50 million +1.1%2.6%4.7 $2.42 11/15/20201,840,000 shares $3.64 million +4.0%2.5%4.8 $1.98 10/30/20201,770,000 shares $3.42 million +22.1%2.4%4.4 $1.93 10/15/20201,450,000 shares $2.48 million -6.5%2.0%3.4 $1.71 9/30/20201,550,000 shares $2.37 million +0.7%2.1%3.1 $1.53 9/15/20201,540,000 shares $2.62 million +19.4%2.1%3.1 $1.70 8/31/20201,290,000 shares $2.21 million -9.8%1.8%2.8 $1.71 8/14/20201,430,000 shares $2.75 million -21.4%2.3%3.3 $1.92 7/31/20201,820,000 shares $3.51 million +9.6%3.8%4.2 $1.93 7/15/20201,660,000 shares $3.49 million -3.5%3.1%6 $2.10 6/30/20201,720,000 shares $4.25 million +8.9%3.9%8.6 $2.47 6/15/20201,580,000 shares $3.98 million -9.7%3.6%7.5 $2.52 5/29/20201,750,000 shares $4.62 million -20.5%3.9%6.9 $2.64 5/15/20202,200,000 shares $3.89 million -4.8%4.9%8.5 $1.77 4/30/20202,310,000 shares $4.30 million -5.3%5.3%10 $1.86 4/15/20202,440,000 shares $4.68 million -2.0%5.6%10 $1.92 3/31/20202,490,000 shares $4.51 million -13.0%6.4%10 $1.81 CASI Short Interest - Frequently Asked Questions What is CASI Pharmaceuticals' current short interest? Short interest is the volume of CASI Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of February 28th, investors have sold 27,400 shares of CASI short. 0.57% of CASI Pharmaceuticals' shares are currently sold short. Learn More on CASI Pharmaceuticals' current short interest. What is a good short interest ratio for CASI Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CASI shares currently have a short interest ratio of 1.0. Learn More on CASI Pharmaceuticals's short interest ratio. Which institutional investors are shorting CASI Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CASI Pharmaceuticals: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for CASI Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.57% of CASI Pharmaceuticals' floating shares are currently sold short. Is CASI Pharmaceuticals' short interest increasing or decreasing? CASI Pharmaceuticals saw a drop in short interest during the month of February. As of February 28th, there was short interest totaling 27,400 shares, a drop of 24.1% from the previous total of 36,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is CASI Pharmaceuticals' float size? CASI Pharmaceuticals currently has issued a total of 15,493,000 shares. Some of CASI Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CASI Pharmaceuticals currently has a public float of 4,770,000 shares. How does CASI Pharmaceuticals' short interest compare to its competitors? 0.57% of CASI Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CASI Pharmaceuticals: ProQR Therapeutics (1.21%), MacroGenics, Inc. (8.86%), Alector, Inc. (7.39%), Organigram Holdings Inc. (6.52%), Zentalis Pharmaceuticals, Inc. (7.53%), Cassava Sciences, Inc. (33.01%), Vaxart, Inc. (5.99%), Enanta Pharmaceuticals, Inc. (13.12%), Genelux Co. (8.16%), Milestone Pharmaceuticals Inc. (1.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short CASI Pharmaceuticals stock? Short selling CASI is an investing strategy that aims to generate trading profit from CASI Pharmaceuticals as its price is falling. CASI shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CASI Pharmaceuticals? A short squeeze for CASI Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CASI, which in turn drives the price of the stock up even further. How often is CASI Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CASI, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies ProQR Therapeutics Short Squeeze MacroGenics Short Squeeze Alector Short Squeeze Organigram Short Squeeze Zentalis Pharmaceuticals Short Squeeze Cassava Sciences Short Squeeze Vaxart Short Squeeze Enanta Pharmaceuticals Short Squeeze Genelux Short Squeeze Milestone Pharmaceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CASI) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CASI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CASI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
